Type II monocytes modulate T cell–mediated central nervous system autoimmune disease

Weber, Martin S, Prod'homme, Thomas, Youssef, Sawsan, Dunn, Shannon E, Rundle, Cynthia D, Lee, Linda, Patarroyo, Juan C, Stüve, Olaf, Sobel, Raymond A, Steinman, Lawrence, Zamvil, Scott S·2007·Nature Medicine
DOI 10.1038/nm1620

Cited by (441)

Items 401–441 of 441

  1. Checkpoints in the Development of Pathogenic and Regulatory T Cells in Experimental Autoimmune Encephalomyelitis—A Basis for Current and Future Interventions in MS
    Denise C. Fitzgerald, Stephen M. Anderton · 2013 · Springer eBooks
  2. T-cell-based therapies for multiple sclerosis
    Tanuja Chitnis, Samia Joseph Khoury · 2011 · Cambridge University Press eBooks
  3. Effect of azithromycin on macrophage phenotype during pulmonary infections and cystic fibrosis
    Theodore James Cory · 2011 · UKnowledge (University of Kentucky)
  4. Modelling Multiple Sclerosis In Vitro and the Influence of Activated Macrophages
    Elly J. F. Vereyken, Christine D. Dijkstra, C.E. Teunisse · 2011 · InTech eBooks
  5. Relação entre o padrão de citocinas secretadas por células de microglia ativadas in vitro e a geração de células T
    Wesley Nogueira Brandão · 2013 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  6. Targeting Antigen Presenting Cells to Treat Autoimmune Inflammation
    Aras Toker · 2009 · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare)
  7. Peptides and Polypeptides as Immunomodulators and Their Consequential Therapeutic Effect in Multiple Sclerosis and Other Autoimmune Diseases
    Ruth Arnon, Michael Sela, Rina Aharoni · 2011 · Wiley eBooks
  8. O fenômeno da tolerância oral e a regulação de células patogênicas Th17 no modelo de encefalomielite experimental auto-imune.
    Jean Pierre Schatzmann Peron · 2008
  9. Genetic and Immunological Mechanisms Regulating Neuroinflammation
    Alan Gillett · 2010 · Figshare
  10. Glatiramer Acetate in the Reduction of Relapse Frequency in Multiple Sclerosis
    Augusto A. Miravalle, Barry A. Hendin, Timothy L. Vollmer, Mrinalini Kala · 2011 · Clinical Medicine Insights Therapeutics
  11. Monocytes take centre stage
    Sharon A. Ahmad · 2007 · Nature reviews. Immunology
  12. MYELOID CELLS IN AUTOIMMUNE DISEASES
    Muhammad Sohel Mia · 2014 · Figshare
  13. Genetic and immunological studies of DCIR in inflammatory arthritis
    Carina Eklöw · 2008 · Figshare
  14. IL-10-differentiated dendritic cells treatment for Experimental Autoimmune Encephalomyelitis (EAE), a model of human Multiple Sclerosis
    Siyuan Xie · 2010 · University Library - University of Saskatchewan (University of Saskatchewan)
  15. PATHOGENIC AND THERAPEUTIC ASPECTS OF INTRATHECAL IMMUNE RESPONSES IN MULTIPLE SCLEROSIS
    Anne Lise Karlsgot Hestvik · 2009 · NORA - Norwegian Open Research Archives
  16. Myeloid corticoid receptors in CNS autoimmunity: Old targets for novel therapies
    Elena Montes Cobos · 2016
  17. Transcriptional Modulation of Tumor-Associated Macrophages to Facilitate Prostate Cancer Immunotherapy
    Alan D. Friedman · 2017
  18. Functional characterization of B- and T lymphocytes after aCD20 treatment in two different EAE models
    Linda Feldmann · 2017 · eDiss (Georg-August-Universität Göttingen)
  19. Papel dos receptores de TNF no desenvolvimento da imunossupressão pós-sepse
    Paulo H. Melo · 2018
  20. Neuroprotective and Neurorestorative Properties of Copolymer-1: Its Immunomodulating Effects on Ischemic Stroke
    Yolanda Cruz, Melanie Tessa Saavedra Navarrete, José Juan Antonio Ibarra Arias · 2020 · IntechOpen eBooks
  21. Peripheral contribution to pain hypersensitivity in a T-cell mediated model of multiple sclerosis: The female perspective
    Muhammad Saad Yousuf · 2020 · ERA: Education and Research Archive (University of Alberta)
  22. Elucidating the Role of Peroxisome Proliferator-activated Receptor (PPAR-δ) in Microglia Cell Function during Experimental Autoimmune Encephalomyelitis (EAE)
    Ellinore R. Doroshenko · 2019 · TSpace (University of Toronto)
  23. The impact of translational research on the development of therapeutic agents for multiple sclerosis
    STANLEY L. COHAN, Elisabeth B. Lucassen, Kyle E. Smoot, Kiren Kresa-Reahl, Meghan C. Romba, Stefanie N. Linch · 2020 · Elsevier eBooks
  24. Distinct Myeloid Cell Subsets with Divergent Functions in Central Nervous System Autoimmunity
    David A. Giles · 2020 · Deep Blue (University of Michigan)
  25. Type II Activation of Monocytes in Multiple Sclerosis
    Delgertsetseg Chuluundorj · 2013
  26. Current World Literature
    2008 · Current Opinion in Allergy and Clinical Immunology
  27. Concomitant multiple sclerosis and polycythemia vera successfully treated with glatiramer acetate
    Ivan Krečak, Sandra Celić-Bunikić, Marko Skelin, Marko Lucijanić, Srđan Verstovšek, Rajko Kušec · 2022 · Annals of Hematology
  28. Introduction
    Peter Hewins, Ronald J. Falk · 2007 · Technical report
  29. Type II Activation of Macrophages and Microglia: Roles in T cell biasing and experimental autoimmune encephalomyelitis
    Sarrabeth Stone · 2013
  30. Faculty Opinions recommendation of Deciphering the Role of B Cells in Multiple Sclerosis-Towards Specific Targeting of Pathogenic Function.
    David L. Selwood · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  31. Pathophysiology and Imaging Diagnosis of Demyelinating Disorders
    Evanthia Bernitsas · 2018 · MDPI eBooks
  32. Osteopontin depletion in macrophages perturbs proteostasis and leads to UCHL1 deficiency and mitochondria-mediated apoptosis
    Maya Koronyo‐Hamaoui, Altan Rentsendorj, Koen Raedschelders, Dieu-Trang S. Fuchs, Julia Sheyn, Vineet Vaibhav, Rebecca A. Porritt, Haoshen Shi, Jargalsaikhan Dagvadorj, Juliana de Freitas Germano et al. · 2022 · Research Square
  33. A Comprehensive Review on Multiple Sclerosis
    S Jayashree, B. Senthilnathan, M Parameshwari, G. Karthikeyan, S. Indhu Pavithra · 2023 · EAS Journal of Pharmacy and Pharmacology
  34. XVI Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2023 (II)
    Óscar Fernández, Xavier Montalbán, Eduardo Agüera, Yolanda Aladro, Ana Alonso, Rafael V. Arroyo González, Luís Brieva, María del Carmen Calles Vázquez, Lucienne Costa-Frossard França, Sara Eichau et al. · 2024 · Revista de Neurología
  35. Additional file 1 of Amelioration of experimental autoimmune encephalomyelitis by in vivo reprogramming of macrophages using pro-resolving factors
    Thierry Gauthier, Omayra Martin-Rodriguez, Cécile Chagué, Anna Daoui, Adam Ceroi, Alexis Varin, Francis Bonnefoy, Séverine Valmary‐Degano, Mélanie Couturier, Susanne Behlke et al. · 2023 · Figshare
  36. Glatiramer acetate stimulates phagocytosis and intracellular killing of Escherichia coli by macrophages and microglial cells
    Jana Seele, Darius Häusler, Roxana Heidemann, Martin S. Weber, Roland Nau · 2026 · Frontiers in Immunology
  37. Cellular immunology of preterm labor and birth and its potential utility for biomarker discovery
    Nardhy Gomez‐Lopez, Dustyn Levenson, SeungBaek Lee, Barbara Neshek, José Galaz · 2026 · Elsevier eBooks
  38. Engineered Glatiramoid Peptides Emulate Glatiramer Acetate Activity in Solid Tumors
    Michelle Oti-Bronya, Huan Gong, Anirban Das, Elise M. Brown, Henry M. Zutter, J. Daniel Griffin, Cory J. Berkland, Jai S. Rudra · 2026 · Molecular Pharmaceutics
  39. BindingDB Entry 50023362: STATs, promising targets for the treatment of autoimmune and inflammatory diseases.
    BindingDB · 2026 · UC San Diego
  40. Clinical trials of multiple sclerosis therapies
    Jeffrey A. Cohen, Richard A. Rudick · 2011 · Cambridge University Press eBooks
  41. B-cell-based therapies for multiple sclerosis
    Emmanuelle L. Waubant, Amit Bar‐Or · 2011 · Cambridge University Press eBooks